To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Circle Pharma grabs $45m Series B
South San Francisco-based Circle Pharma Inc, a macrocycle drug discovery and development company focused on intractable cancer targets, has raised $45 million in Series B financing.
